Special Issue Cancerscience-2011
Share This Page Share
 
TRACK6 (iii): Therapeutic Targets in Cancer
           6(iv): Clinical Research in Cancer Immunology
 
 
 

JCST 2011/S9: 1948-5956-10000S9-1/Special Issue 2011
doi: 10.4172/1948-5956.10000S9

Targeting superoxide dismutase 1 for chemosensitization of platinum resistant ovarian cancer cells
Mu Wang

s s 

pdf

 

JCST 2011/S9: 1948-5956-10000S9-2/Special Issue 2011
doi: 10.4172/1948-5956.10000S9

Unresolved infl ammation: Immune dynamics of aging process and tumorigenesis
Mahin Khatami

s s 

pdf

 

JCST 2011/S9: 1948-5956-10000S9-3/Special Issue 2011
doi: 10.4172/1948-5956.10000S9

IPMN of the pancreas - Evaluation of pathohistological subtypes and clinical outcome
Marius Distler

s s 

pdf

 

JCST 2011/S9: 1948-5956-10000S9-4/Special Issue 2011
doi: 10.4172/1948-5956.10000S9

Using GlycoExpress for production of highly active antibodies directed against novel and existing targets
Steffen Goletz

s s 

pdf

 

JCST 2011/S9: 1948-5956-10000S9-5/Special Issue 2011
doi: 10.4172/1948-5956.10000S9

BiTE Antibodies for Cancer Therapy
Patrick A. Baeuerle and Roman Kischel

s s 

pdf

 

JCST 2011/S9: 1948-5956-10000S9-6/Special Issue 2011
doi: 10.4172/1948-5956.10000S9

Lactobacillus casei ssp.casei could induce the Th1 cytokine production and Natural Killer cells activity in BALB/c mice bearing invasive ductal carcinoma
Mohammad Mehdi Soltan Dallal, Mohammad Hossein Yazdi, Marzieh Holakuyee, Zuhair Mohammad Hassan, Abbas Mirshafiey and Mehdi Mahdavi

s s 

pdf

 

JCST 2011/S9: 1948-5956-10000S9-7/Special Issue 2011
doi: 10.4172/1948-5956.10000S9

Clinical Pharmacokinetics of Cisplatin in Patients with Malignant Tumor of Limb (MAL) by Hyperthermic Antiblastic Perfusion (HAP) Treatment
Jianshi Lou, Jing Zhu and Zhiqing Cui

s s 

pdf

 

JCST 2011/S9: 1948-5956-10000S9-8/Special Issue 2011
doi: 10.4172/1948-5956.10000S9

Impaired cytolytic function of natural killer (NK) cells obtained from patients with head and neck cancer can be partially restored by the triggering of toll-like receptor 3 (TLR3) expressed on NK cells
Miroslaw J. Szczepanski

s s 

pdf

 

JCST 2011/S9: 1948-5956-10000S9-9/Special Issue 2011
doi: 10.4172/1948-5956.10000S9

Targeted and image-guided cancer treatment using Theranostic nanoparticles
Lily Yang

s s 

pdf

 
   S3»   S4»   S5»   S6»   S7»   S8»   S9»   S10»   S11»   S12»   S13»